Novel SCN5A mutations in two families with "brugada-like" ST elevation in the inferior leads and conduction disturbances

Journal of Interventional Cardiac Electrophysiology

Volumn 37, Issue 2, 2013, Pages 131-140

  Maury, Philippe ^a   Moreau, Adrien ^b,c   Hidden Lucet, Francoise ^d,e,f   Leenhardt, Antoine ^g,h,i   Fressart, Veronique ^d   Berthet, Myriam ^e,f   Denjoy, Isabelle ^e,f,g   Bennamar, Nawal ^d   Rollin, Anne ^a   Cardin, Christelle ^a   Guicheney, Pascale ^e,f   Chahine, Mohamed ^b,c  

^a CHU RANGUEIL   (France)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSERM   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g BICHAT HOSPITAL   (France)

^h HÔPITAL LARIBOISIÈRE   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Brugada; Conduction disturbance; Overlap syndrome; SCN5A; ST elevation

Indexed keywords

AJMALINE; AMIODARONE; LIDOCAINE; MEXILETINE;

ADULT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; DRUG INTOXICATION; ECG ABNORMALITY; ELECTROPHYSIOLOGY; FOLLOW UP; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE CONDUCTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTENSIVE CARE UNIT; ION TRANSPORT; LOW TEMPERATURE; MALE; MEDICAL HISTORY; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PR INTERVAL; PRIORITY JOURNAL; QRS COMPLEX; SINUS BRADYCARDIA; SODIUM CURRENT; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STOP CODON; THYROTOXICOSIS; WILD TYPE;

ADOLESCENT; BRUGADA SYNDROME; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84879506406     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-013-9805-7     Document Type: Article

References (38)

1. Antzelevitch, C., Brugada, P., Borggrefe, M., Brugada, J., Brugada, R., Corrado, D., et al. (2005). Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation, 111, 659-670.
2. Potet, F., Mabo, P., Le Coq, G., Probst, V., Schott, J. J., Airaud, F., et al. (2003). Novel brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads. Journal of Cardiovascular Electrophysiology, 14, 200-203.
3. Riera, A. R., Ferreira, C., Schapachnik, E., Sanches, P. C., & Moffa, P. J. (2004). Brugada syndrome with atypical ECG: downsloping ST-segment elevation in inferior leads. J Electrocardiol, 37, 101-104.
4. Lombardi, F., Potenza, S., Beltrami, A., Verzoni, A., Brugada, P., & Brugada, R. (2007). Simultaneous ST-segment elevation in the right precordial and inferior leads in Brugada syndrome. Journal of Cardiovascular Medicine (Hagerstown, Md.), 8, 201-204.
5. Van den Berg, M. P., & Wiesfeld, A. C. (2006). Brugada syndrome with ST-segment elevation in the lateral leads. Journal of Cardiovascular Electrophysiology, 17, 1035.
6. Bonakdar, H., Haghjoo, M., & Sadr-Ameli, M. A. (2008). Brugada syndrome manifested by the typical electrocardiographic pattern both in the right precordial and the high lateral leads. Indian Pacing Electrophysiol J, 8, 137-140.
7. Kawamura, M., Ozawa, T., Yao, T., Ashihara, T., Sugimoto, Y., Yagi, T., et al. (2009). Dynamic change in ST-segment and spontaneous occurrence of ventricular fibrillation in Brugada syndrome with a novel nonsense mutation in the SCN5A gene during long-term follow-up. Circulation Journal, 73, 584-588.
8. Sassone, B., Sacca, S., & Donateo, M. (2006). Paradoxical effect of ajmaline in a patient with Brugada syndrome. Europace, 8, 251-254.
9. Porres, J. M., Brugada, J., Urbistondo, V., García, F., Reviejo, K., & Marco, P. (2002). Fever unmasking the Brugada syndrome. Pacing and Clinical Electrophysiology, 25, 1646-1648.
10. Sarkozy, A., Chierchia, G. B., Paparella, G., Boussy, T., De Asmundis, C., Roos, M., et al. (2009). Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circulation. Arrhythmia and Electrophysiology, 2, 154-161.
11. Batchvarov, V. N., Govindan, M., Camm, A. J., & Behr, E. R. (2009). Brugada-like changes in the peripheral leads during diagnostic ajmaline test in patients with suspected Brugada syndrome. Pacing and Clinical Electrophysiology, 32, 695-703.
12. Kapplinger, J. D., Tester, D. J., Alders, M., Benito, B., Berthet, M., Brugada, J., et al. (2010). An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm, 7, 33-46.
13. Baroudi, G., Pouliot, V., Denjoy, I., Guicheney, P., Shrier, A., & Chahine, M. (2001). Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Circulation Research, 88, E78-83.
14. Valdivia, C. R., Tester, D. J., Rok, B. A., Porter, C. B., Munger, T. M., Jahangir, A., et al. (2004). A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs. Cardiovascular Research, 62, 53-62.
15. Jiang, C., Atkinson, D., Towbin, J. A., Splawski, I., Lehmann, M. H., Li, H., et al. (1994). Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nature Genetics, 8, 141-147.
16. Schott, J. J., Alshinawi, C., Kyndt, F., Probst, V., Hoorntje, T. M., Hulsbeek, M., et al. (1999). Cardiac conduction defects associate with mutations in SCN5A. Nature Genetics, 23, 20-21.
17. Tan, H. L., Bink-Boelkens, M. T., Bezzina, C. R., Viswanathan, P. C., Beaufort-Krol, G. C., van Tintelen, P. J., et al. (2001). A sodium-channel mutation causes isolated cardiac conduction disease. Nature, 409, 1043-1047.
18. Huang, H., Priori, S. G., Napolitano, C., O'Leary, M. E., & Chahine, M. (2011). Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels. American Journal of Physiology. Heart and Circulatory Physiology, 300, H288-299.
19. Deschênes, I., Baroudi, G., Berthet, M., Barde, I., Chalvidan, T., Denjoy, I., et al. (2000). Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Cardiovascular Research, 46, 55-65.
20. Teng, S., Gao, L., Paajanen, V., Pu, J., & Fan, Z. (2009). Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels. Cardiovascular Research, 83, 473-480.
21. Baroudi, G., Napolitano, C., Priori, S. G., Del Bufalo, A., & Chahine, M. (2004). Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome. The Canadian Journal of Cardiology, 20, 425-430.
22. Keller, D. I., Rougier, J. S., Kucera, J. P., Benammar, N., Fressart, V., Guicheney, P., et al. (2005). Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovascular Research, 67, 510-519.
23. Zhao, J., Ziane, R., Chatelier, A., O'Leary, M. E., & Chahine, M. (2007). Lidocaine promotes the trafficking and functional expression of Na(v)1.8 sodium channels in mammalian cells. Journal of Neurophysiology, 98, 467-477.
24. Kyndt, F., Probst, V., Potet, F., Demolombe, S., Chevallier, J. C., Baro, I., et al. (2001). Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation, 104, 3081-3086.
25. Six, I., Hermida, J. S., Huang, H., Gouas, L., Fressart, V., Benammar, N., et al. (2008). The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases. Europace, 10, 79-85.
26. Makiyama, T., Akao, M., Tsuji, K., Doi, T., Ohno, S., Takenaka, K., et al. (2005). High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. Journal of the American College of Cardiology, 46, 2100-2106.
27. Vatta, M., Dumaine, R., Varghese, G., Richard, T. A., Shimizu, W., Aihara, N., et al. (2002). Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Human Molecular Genetics, 11, 337-345.
28. Zhang, Y., Wang, T., Ma, A., Zhou, X., Gui, J., Wan, H., et al. (2008). Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel. Acta Physiologica (Oxford, England), 194, 311-323.
29. Zimmer, T., Biskup, C., Dugarmaa, S., Vogel, F., Steinbis, M., Böhle, T., et al. (2002). Functional expression of GFP-linked human heart sodium channel (hH1) and subcellular localization of the a subunit in HEK293 cells and dog cardiac myocytes. Journal of Membrane Biology, 186, 1-12.
30. Antzelevitch C, Fish JM, Di Diego JM. (2007) Cellular mechanisms underlying the brugada syndrome. In C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada (Eds.), The brugada syndrome: from bench to bedside (pp. 52-77). Oxford: Blackwell Science Ltd.
31. Perez Riera AR, Ferreira C, Schapachnik E. (2007) Value of 12 lead electrocardiogram and derived methodologies in the diagnosis of Brugada disease. In C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada (Eds.), The Brugada syndrome: from bench to bedside (pp. 87-110). Oxford: Blackwell Science Ltd.
32. Shu, J., Zhu, T., Yang, L., Cui, C., & Yan, G. X. (2005). ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: cellular and clinical linkage. Journal of Electrocardiology, 38(4 Suppl), 26-32.
33. Wichter, T., Matheja, P., Eckardt, L., Kies, P., Schäfers, K., Schulze-Bahr, E., et al. (2002). Cardiac autonomic dysfunction in Brugada syndrome. Circulation, 105, 702-706.
34. Meregalli, P. G., Wilde, A. A., & Tan, H. L. (2005). Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovascular Research, 67, 367-378.
35. Probst, V., Allouis, M., Sacher, F., Pattier, S., Babuty, D., Mabo, P., et al. (2006). Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. Journal of Cardiovascular Electrophysiology, 17, 270-275.
36. Rossenbacker, T., Carroll, S. J., Liu, H., Kuipéri, C., de Ravel, T. J., Devriendt, K., et al. (2004). Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death. Heart Rhythm, 1, 610-615.
37. Smits, J. P., Koopmann, T. T., Wilders, R., Veldkamp, M. W., Opthof, T., Bhuiyan, Z. A., et al. (2005). A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. Journal of Molecular and Cellular Cardiology, 38, 969-981.
38. Postema, P. G., Van den Berg, M., Van Tintelen, J. P., Van den Heuvel, F., Grundeken, M., Hofman, N., et al. (2009). Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide. Neth Heart J, 17, 422-428.